Phase I study of AEE788, a novel multitarget inhibitor of ErbB- and VEGF-receptor-family tyrosine kinases, in recurrent glioblastoma patients - Concepedia

Concepedia

Publication | Closed Access

Phase I study of AEE788, a novel multitarget inhibitor of ErbB- and VEGF-receptor-family tyrosine kinases, in recurrent glioblastoma patients

60

Citations

41

References

2012

Year

David A. Reardon, Charles A. Conrad, Timothy F. Cloughesy, Michael D. Prados, Henry S. Friedman, Kenneth Aldape, Paul S. Mischel, Jane Xia, Clifford DiLea, Jerry Huang,

Cancer Chemotherapy and Pharmacology

Neuro-oncologyRecurrent Glioblastoma PatientsMedicineReceptor Tyrosine KinasePharmacologyNovel Multitarget InhibitorVegf-receptor-family Tyrosine KinasesAnti-cancer AgentHigh-grade GliomasCancer TreatmentRadiation OncologyOncologyGlioma

References

	Year	Citations

Page 1

Page 1